Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05030415 · ClinicalTrials.gov registry record · Early Phase 1
Ixekizumab in Adult Patients With Lichen Planus and Lichen Planopilaris
A Early Phase 1 study of Lichen Planus and Lichen Plano-Pilaris, sponsored by University of New Mexi.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT05030415: Completed Early Phase 1 study of Lichen Planus and Lichen Plano-Pilaris, sponsored by University of New Mexi.
NCT05030415 is a Early Phase 1 study of Lichen Planus and Lichen Plano-Pilaris that has completed, run by University of New Mexi. The registered enrollment target is 9 participants, below the 140-participant average among 3 other Lichen Planus trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05030415, a Early Phase 1 study of Lichen Planus and Lichen Plano-Pilaris, has completed, sponsored by University of New Mexi.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the safety and efficacy of ixekizumab in lichen planus and lichen planopilaris clinical response by Total Body Surface (TBS) determination, Investigator Global Assessment (IGA) Score, Lichen Planopilaris Activity Index (LPPAI), and Frontal Fibrosing Alopecia Severity Score (FFASS).
Primary Outcome
Change in IGA
Conditions Studied
Interventions
- DRUG Ixekizumab Auto-Injector
Study Locations (1)
New Mexico
- University of New Mexico - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2021-08-12 |
| Est. Completion | 2024-03-25 |
| Phase | Early Phase 1 |
What the finished NCT05030415 record still lists
NCT05030415 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 140-participant average among 3 other Lichen Planus trials with a reported enrollment target (94% lower).
The record links to 3 conditions, with Lichen Planus appearing as the primary indexed condition, and to 1 intervention - of which Ixekizumab Auto-Injector is the first listed.
NCT05030415 reports a single indexed study location in New Mexico.
Frequently Asked Questions
What is clinical trial NCT05030415 about?
NCT05030415 is a clinical study titled "Ixekizumab in Adult Patients With Lichen Planus and Lichen Planopilaris". To evaluate the safety and efficacy of ixekizumab in lichen planus and lichen planopilaris clinical response by Total Body Surface (TBS) determination, Investigator Global Assessment (IGA) Score, Lichen Planopilaris Activity Index (LPPAI), and Frontal Fibrosing Alopecia Severity Score (FFASS).
What is the current status of trial NCT05030415?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 9 participants. The study started on 2021-08-12. Estimated completion is 2024-03-25.
What conditions does trial NCT05030415 study?
This clinical trial studies the following conditions: Lichen Planus, Lichen Plano-Pilaris, Lichen Planus Scalp.
What interventions are being tested in trial NCT05030415?
The interventions under investigation include: Ixekizumab Auto-Injector (DRUG).
Who is sponsoring clinical trial NCT05030415?
This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05030415 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lichen Planus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI